Xuezhen Zeng
Meigang South Road, 518000
Shenzhen, China
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 05, 2025
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 23, 2025
Anti-PD-1 synergizes with RFA to suppress abscopal tumors and induce durable memory against recurrence in HCC.
Journal: Liver research (Beijing, China)
Published: April 01, 2025
Editorial: Role of fibroblast in cancer.
Journal: Frontiers in molecular biosciences
Published: February 11, 2025
Single-Cell Transcriptomic Analysis Reveals an Aggressive Basal-Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Journal: Journal of gastroenterology and hepatology
Published: November 30, 2024
Circulating inflammatory cytokines influencing schizophrenia: a Mendelian randomization study.
Journal: Frontiers in psychiatry
Published: April 14, 2024
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC.
Journal: Hepatology (Baltimore, Md.)
Published: February 19, 2023
A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: October 27, 2022
Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective.
Journal: Frontiers in immunology
Published: August 31, 2022
Last Updated: 09/26/2026